Insuman Rapid Solostar

Insulin Human, the active ingredient in Insuman Rapid Solostar, is an insulin presented as a clear solution for injection for subcutaneous use. It is indicated for the management of hyperglycemia in both Type 1 and Type 2 diabetes mellitus, providing rapid onset of action to help patients achieve target glucose levels. The product conforms to European Union regulatory standards and is available in multi‑dose vials for clinical use.

GNH USA supplies Insuman Rapid Solostar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Rapid Solostar is a rapid‑acting insulin that lowers blood glucose by facilitating cellular uptake.

- Type 1 diabetes mellitus: provides rapid glucose control to maintain target blood sugar levels. - Type 2 diabetes mellitus: assists in achieving glycemic targets when oral agents are insufficient. - Hyperglycemia in hospitalized patients: enables rapid correction of elevated glucose levels during acute care.

Insuman Rapid Solostar may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects: - Hypoglycemia: symptoms such as sweating, tremor, or confusion. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: increase in body weight over time. - Lipodystrophy: localized fat tissue changes at injection sites.

Serious or Rare Side Effects: - Severe hypoglycemia: loss of consciousness or seizures. - Allergic reactions: rash, urticaria, or anaphylaxis. - Edema: swelling of extremities. - Hypersensitivity: serum‑sickness–like symptoms.

When using Insuman Rapid Solostar, several precautions should be observed to ensure safety and effectiveness.

- Dose titration: adjust based on self‑monitoring of blood glucose. - Hypoglycemia risk: educate patients on recognizing and treating low glucose episodes. - Concomitant medications: review drugs that may mask hypoglycemia symptoms. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Driving and operating machinery: avoid if experiencing hypoglycemia. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Rapid Solostar can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Other insulins or insulin secretagogues: may cause severe hypoglycemia. - Beta‑blockers: can mask hypoglycemia symptoms. - Alcohol: can potentiate insulin’s glucose‑lowering effect.

Moderate Interactions (Monitor Closely): - ACE inhibitors and ARBs: may enhance insulin’s glucose‑lowering effect. - Thiazide diuretics: may reduce insulin sensitivity. - Corticosteroids: may increase glucose levels, requiring dose adjustment.